Restrictions and fear on the Hormuz Strait have fractured supply chains, especially for primary materials used in pharmaceutical packaging.
- May 2026 — CDMO Opportunities And Threats Report
- In Vivo Gene Editing Is Moving From Promise To Proof
- Why Improving Drug Delivery Remains A Major Opportunity In Oncology
- FDA's Guidance On Cell And Gene CMC Codifies Flexibility
- Strategic Synthesis Of ASGCT And ASCO 2026
- Emerging Technologies In Aseptic Processing: Hype Vs. Operational Reality
- Use Of AI In FDA Inspection Activities: Strategies For Effective Preparation
- A Comparison Of 6 Analytical Validation Guidelines Using Data Envelopment Analysis
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Fragment-Analyzer_Agilent_0544_screen]( "Preventive Control Of Sequencing Through The Insert")
Preventive Control Of Sequencing Through The InsertUnderstanding library size distributions helps prevent sequencing through the insert, reducing adapter read‑through. Explore how smear analysis guides optimal read‑length selection to avoid noise.
-
![iStock-899483138 lab freeze cold 450x300.jpg]( "A Comparative Analysis Between Liquid Nitrogen And Mechanical Freezers")
A Comparative Analysis Between Liquid Nitrogen And Mechanical FreezersExplore the differences between liquid nitrogen and mechanical cryogenic freezers, and learn how each method supports scientific, medical, and industrial storage needs.
-
![GettyImages-1935725164-disease-cell-blue]( "3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived Neurons")
3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived NeuronsExplore how different ApoE alleles influence Alzheimer's Disease risk using iPSC-derived neurons as well as gain insights into AD mechanisms and potential therapies.
-
![GettyImages-2163836351_DNA_Cell Gene]( "AAV-Based Gene Editing For Huntington's Disease")
AAV-Based Gene Editing For Huntington's DiseaseLETI-101 uses AAV5 to deliver a compact CRISPR system for allele-selective editing of mutant HTT, showing promise as a one-time treatment for Huntington’s disease with strong preclinical safety and efficacy.
-
![Thermo Fisher - Peptones]( "The Value Of Peptones For Enhancing Biopharmaceutical Productivity")
The Value Of Peptones For Enhancing Biopharmaceutical ProductivityPeptones, versatile media additives derived from various sources, offer numerous benefits for biopharmaceutical production.
-
![GettyImages-2183234647 AAV]( "Three-Dimensional Linkage Analysis With Digital PCR For Genome Integrity")
Three-Dimensional Linkage Analysis With Digital PCR For Genome IntegrityA cost-effective approach with a comprehensive AAV analytical package holds the potential to advance the application of rAAV in cell and gene therapy for the treatment of human diseases.
-
![GettyImages-824641956 monoclonal antibody]( "Analytical Approach For Bispecific Antibody Quality Study")
Analytical Approach For Bispecific Antibody Quality StudyBispecific antibody quality control demands advanced analytics to detect mispaired species, assess structural integrity, and confirm potency, ensuring safety and efficacy across diverse therapeutic applications.
-
![GettyImages-499481438 isolator]( "Turnkey Dismantling, Modification, And Relocation Of A Multi-Glove Isolator System")
Turnkey Dismantling, Modification, And Relocation Of A Multi-Glove Isolator SystemStrategic equipment relocation and retrofitting can reduce capital costs by fifty percent and save months in lead time. Learn how to modernize legacy systems while maintaining full GMP compliance.
-
![Parexel_PaidADs_HighRes]( "Navigating The Challenges Of Large, International Phase III Breast Cancer Trials")
Navigating The Challenges Of Large, International Phase III Breast Cancer TrialsIn the competitive landscape of breast cancer research, aligning biomarker testing, regulatory pathways, and regional operations from day one creates a path to faster enrollment and stronger outcomes.
-
![GettyImages-1790778296-laboratory-research-sample-prep]( "Streamlining Analytical Release Testing With Faster, Smaller Workflows")
Streamlining Analytical Release Testing With Faster, Smaller WorkflowsReducing turnaround times and sample volumes in release testing can accelerate cell therapy manufacturing, preserve product yield, and improve patient outcomes.
NEWSLETTER ARCHIVE
- 06.19.26 -- Redefining CAR-T Timing And Patient Access With Allogene Therapeutics' Dr. Zachary Roberts
- 06.18.26 -- Tools And Technologies Enabling Next-Generation Cell Therapies
- 06.18.26 -- Scale Vaccine Production With Proven Cell Culture Solutions
- 06.18.26 -- Inside AstraZeneca's Fully Electrified Cell Therapy Facility
- 06.17.26 -- What's Slowing Your Cell & Gene Therapy Program?
- In Vivo Gene Editing Is Moving From Promise To Proof
- Driving Gene Therapy Beyond Rare Disease Will Define The Next Era Of CGT
- CGT Manufacturing Shifts From Capacity To Strategy
- Dr. Peter Marks On Why Gene Therapy May Need A New Regulatory Playbook
- Regeneron Advances In Vivo Gene Therapy For Hearing Loss
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
